Publications by authors named "Suraj Konnath George"

7Publications

Dual inhibition of IGF-IR and ALK as an effective strategy to eradicate NPM-ALK T-cell lymphoma.

Authors:
Bhawana George Suraj Konnath George Wenyu Shi Abedul Haque Ping Shi Ghazaleh Eskandari Magnus Axelson Olle Larsson Ahmed O Kaseb Hesham M Amin

J Hematol Oncol 2019 07 24;12(1):80. Epub 2019 Jul 24.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Unit 072, 1515 Holcombe Boulevard, Houston, TX, 77030, USA.

View Article and Find Full Text PDF
July 2019

TrkA is a binding partner of NPM-ALK that promotes the survival of ALK T-cell lymphoma.

Authors:
Wenyu Shi Suraj Konnath George Bhawana George Choladda V Curry Albina Murzabdillaeva Serhan Alkan Hesham M Amin

Mol Oncol 2017 09 18;11(9):1189-1207. Epub 2017 Jun 18.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF
September 2017

Type I insulin-like growth factor receptor signaling in hematological malignancies.

Authors:
Deeksha Vishwamitra Suraj Konnath George Ping Shi Ahmed O Kaseb Hesham M Amin

Oncotarget 2017 Jan;8(1):1814-1844

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF
January 2017

Validation of a Preclinical Model of Diethylnitrosamine-Induced Hepatic Neoplasia in Yucatan Miniature Pigs.

Authors:
Jennifer Mitchell Peggy T Tinkey Rony Avritscher Carolyn Van Pelt Ghazaleh Eskandari Suraj Konnath George Lianchun Xiao Erik Cressman Jeffrey S Morris Asif Rashid Ahmed O Kaseb Hesham M Amin Rajesh Uthamanthil

Oncology 2016 16;91(2):90-100. Epub 2016 Jun 16.

Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, Tex., USA.

View Article and Find Full Text PDF
January 2017

Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms.

Authors:
Lujun Yang Shuangfeng Zhang Suraj Konnath George Rong Teng Xuefen You Mengqi Xu Hong Liu Xiaoping Sun Hesham M Amin Wenyu Shi

Oncotarget 2015 Jun;6(17):14953-69

Department of Hematology, Affiliated Hospital of The University of Nantong, Jiangsu 226001, China.

View Article and Find Full Text PDF
June 2015

The ALK inhibitor ASP3026 eradicates NPM-ALK⁺ T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model.

Authors:
Suraj Konnath George Deeksha Vishwamitra Roxsan Manshouri Ping Shi Hesham M Amin

Oncotarget 2014 Jul;5(14):5750-63

Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX; The University of Texas Graduate School of Biomedical Sciences, Houston, TX.

View Article and Find Full Text PDF
July 2014

Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen.

Authors:
Suraj Konnath George Veronica Tovar-Sepulveda Steven S Shen Weiguo Jian Yiqun Zhang Susan G Hilsenbeck Seth P Lerner Carolyn L Smith

Transl Oncol 2013 Jun 1;6(3):244-55. Epub 2013 Jun 1.

Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX.

View Article and Find Full Text PDF
June 2013